Prescribers and pharmaceutical representatives: why are we still meeting? - Wikidata - awgldk - TriplyDB

Prescribers and pharmaceutical representatives: why are we still meeting?

Prescribers and pharmaceutical representatives: why are we still meeting?

http://www.wikidata.org/entity/Q37225206

about

Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study.Physicians' perceptions of medical representative visits in Yemen: a qualitative study.Interactions between non-physician clinicians and industry: a systematic review.A randomized trial evaluating 2 approaches for promoting pharmacy-based referrals to the tobacco quitline: methods and baseline findings."We can't get along without each other": Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety.Medical Schools' Industry Interaction Policies Not Associated With Trainees' Self-Reported Behavior as Residents: Results of a National Survey.Attitude and practice of dental surgeons towards pharmaceutical companies' marketing gifts Which pharmaceutical sales representatives' features do slovenian family physicians value?Dissemination, adoption, and implementation of acamprosate for treating alcohol use disorders.The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.The Physician Payments Sunshine Act and the unaddressed role of nurses: an interest group analysis.Pharmacist-industry relationships.Beliefs, perceptions and behaviours of GPs towards generic medicines.Is there a doctor in the house? : The presence of physicians in the direct-to-consumer genetic testing context.Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.Multilevel analysis of the influence of patients' and general practitioners' characteristics on patented versus multiple-sourced statin prescribing in France.Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.The social biography of antibiotic use in smallholder dairy farms in India.

P2860

Q28071334-E7F9A6F2-7E70-4EAE-92C2-679EE1F3374C Q28475841-68323008-95EA-4E57-97C7-BE3A028A216A Q34215520-77500033-EFEA-479A-8F56-409DBDDCA4E9 Q34337342-16448EEA-602E-4412-831B-0CD8F3438DFF Q34958916-321D6BBC-C5C7-480D-89F1-27932D9C7F73 Q35058414-2C75259C-1FD5-4D45-A6B9-CBE7A9B7548E Q36191989-45290881-50D8-423A-8C45-605A9DA99C4A Q36328375-966A2ED2-C02E-44B3-9864-BD47A5E43415 Q36362502-8A8FB7A2-63E1-4FCF-9A39-6EF601A5E630 Q37086791-5687149D-1646-48EE-83B0-1AC981B1C2C9 Q37562476-373996E6-B790-42FF-892E-85ED6A0FD88A Q37729024-FE8623A6-DC3A-4B3A-983D-FE11354D486C Q37729027-74859CF8-CF85-4D16-B41B-932838B44F70 Q38082293-EACA5FED-3194-4A13-9F2F-9BD3C73BC1E4 Q38769174-32DB1BAE-803E-45B6-BEB4-7DE4E8384E36 Q40197904-01E9AAB8-3F3E-42E3-9B3A-CD23008E9B28 Q41959048-767E67A6-2D9F-4614-8A19-A7BBA16B8225 Q42215595-E2E1B006-89AA-42EF-9B6A-80BB09190BD0 Q44132532-99A343D8-539C-4E8C-AB7E-C011AC8FA42F Q47657946-6699AE68-F32D-40F6-A9BC-1C6600E182D1 Q53685091-3DBC13E0-D69E-422F-8506-B54F6302A626

P2860

Prescribers and pharmaceutical representatives: why are we still meeting?

http://www.wikidata.org/entity/Q37225206

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prescribers and pharmaceutical representatives: why are we still meeting?

@en

Prescribers and pharmaceutical representatives: why are we still meeting?

@nl

type

label

Prescribers and pharmaceutical representatives: why are we still meeting?

@en

Prescribers and pharmaceutical representatives: why are we still meeting?

@nl

prefLabel

Prescribers and pharmaceutical representatives: why are we still meeting?

@en

Prescribers and pharmaceutical representatives: why are we still meeting?

@nl

P1433

Q37225206-AD701E45-D7AB-4F46-A56C-5015AB43F150

P1476

Q37225206-BD1B0EAE-FD56-47CB-9350-CC352431F0EA

P2093

Q37225206-1039A1EC-CD96-489A-99B5-605E9E1A0ABD

Q37225206-17F07E68-474C-4DB5-ABE2-EC17E69E388C

Q37225206-2278ADF5-59FA-4BC8-825E-B36F1BE4E489

Q37225206-75505F52-37FA-4221-96B3-9A99F244DE77

Q37225206-8EEA3740-48F9-4410-AE96-3B260AD9EDFC

Q37225206-9825701F-69F5-4BAF-87A7-DA3363E34517

Q37225206-98F70EE9-66D6-4382-91B5-4C7C951E0438

Q37225206-9D52AF4E-885C-49C5-8B48-B0F50F2359B5

P2860

Q37225206-0EB83057-195D-4944-8FFA-0963C7F57772

Q37225206-122AABBE-B8C3-459C-A3A6-5A6D1F3A97D6

Q37225206-1BBAA3AE-BDCB-476B-872C-5EE4EDEB1559

Q37225206-256E397C-D3FF-4E67-AD3F-A5E83DA7579B

Q37225206-298FA46F-AB72-42B7-A7E0-1DCFDF4463EC

Q37225206-29D0C970-E3D5-4CA5-AD4B-B50453C65701

Q37225206-39C44C13-743C-43B7-891A-A247339BBADC

Q37225206-3D7F1748-31B9-4FDD-9439-EECC8D3CFB66

Q37225206-5404FDCA-6FE1-4334-A28B-F9836FA6C516

Q37225206-572F66CF-A02E-4E80-A30A-528A6499BF73

P2888

Q37225206-67C51A80-9922-4F31-B748-0C8695772818

P304

Q37225206-63B24734-CE97-40BB-854A-3C75ACDE316F

P31

Q37225206-4BFAF5E7-4296-4730-B93A-986F2A5BB2F3

P356

Q37225206-9818685F-0921-4960-8BF6-F8E1024415D1

P433

Q37225206-3B10C01E-8940-4332-BFF8-FEC09747C2A1

P478

Q37225206-32A7B6E9-38D4-40F1-B6C5-2D79AB37E8CC

P577

Q37225206-38C0CD3D-2E79-4F80-B080-A728822DCD70

P5875

Q37225206-28F624F3-631B-4F7B-AE5F-A950A27093A7

P698

Q37225206-BF28F5A8-739D-4C8F-8308-81268B1C9C39

P932

Q37225206-55FFEC5B-F660-42E9-A00F-10BADD510DAB

P356

S11606-009-0989-6

P1433

Journal of General Internal Medicine

P1476

Prescribers and pharmaceutical representatives: why are we still meeting?

@en

P2093

Ann Von Worley

http://www.w3.org/2001/XMLSchema#string

Elissa Ladd

http://www.w3.org/2001/XMLSchema#string

Jerry H Gurwitz

http://www.w3.org/2001/XMLSchema#string

Joann L Baril

http://www.w3.org/2001/XMLSchema#string

Kathleen M Mazor

http://www.w3.org/2001/XMLSchema#string

Laura Saccoccio

http://www.w3.org/2001/XMLSchema#string

Mary Ellen Keough

http://www.w3.org/2001/XMLSchema#string

Melissa A Fischer

http://www.w3.org/2001/XMLSchema#string

P2860

Following the script: how drug reps make friends and influence doctors

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Interactions between pharmaceutical representatives and doctors in training. A thematic review

Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes

Principles of educational outreach ('academic detailing') to improve clinical decision making.

Soft targets: nurses and the pharmaceutical industry.

Physicians and the pharmaceutical industry: is a gift ever just a gift?

Understanding why GPs see pharmaceutical representatives: a qualitative interview study

Stages of change and decisional balance for 12 problem behaviors.

Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications, 1975-2000.

P2888

s11606-009-0989-6

P304

795-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11606-009-0989-6

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24410662

http://www.w3.org/2001/XMLSchema#string

P698

19424764

http://www.w3.org/2001/XMLSchema#string

P932

2695530

http://www.w3.org/2001/XMLSchema#string